Iron depletion: A defense against intracellular infection and neoplasia
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 50 (18) , 1289-1297
- https://doi.org/10.1016/0024-3205(92)90279-x
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.The Journal of Experimental Medicine, 1991
- Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophagesBiochemical and Biophysical Research Communications, 1991
- Physiological importance of nitric oxide.BMJ, 1991
- Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron.Journal of Clinical Investigation, 1989
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediateBiochemistry, 1988
- Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.Journal of Clinical Investigation, 1988
- Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.Journal of Clinical Investigation, 1986
- Arginine: Biochemistry, Physiology, and Therapeutic ImplicationsJournal of Parenteral and Enteral Nutrition, 1986
- Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophagesBiochemical and Biophysical Research Communications, 1984